Accordingly, Farrell et al. showed that knockdown of a PP2A inhibitor could increase c-Myc degradation and decrease the tumorigenic potential of pancreatic cancer cells [33]. The gene discussed is PTPA; the disease is familial pancreatic carcinoma.